# Sequential or Concurrent Chemoradiotherapy in Patients With Locoregionally Advanced NPC

> **NCT03366415** · PHASE3 · UNKNOWN · sponsor: **Chaosu Hu** · enrollment: 420 (estimated)

## Conditions studied

- Nasopharyngeal Carcinoma

## Interventions

- **DRUG:** gemcitabine and cisplatin (Induction and adjuvant chemotherapy)
- **RADIATION:** IMRT
- **DRUG:** gemcitabine and cisplatin (Induction chemotherapy)
- **RADIATION:** IMRT and concurrent cisplatin

## Key facts

- **NCT ID:** NCT03366415
- **Lead sponsor:** Chaosu Hu
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-01-01
- **Primary completion:** 2024-09-30
- **Final completion:** 2024-12-30
- **Target enrollment:** 420 (ESTIMATED)
- **Last updated:** 2022-03-04

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03366415

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03366415, "Sequential or Concurrent Chemoradiotherapy in Patients With Locoregionally Advanced NPC". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03366415. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*